Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy-Reference-Cited by-同舟云学术

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy

Published:2017-10-04 Issue:410 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Pinter Matthias¹²^ORCID,Jain Rakesh K.¹^ORCID

Affiliation:

1. Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114, USA.

2. Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, A-1090, Austria.

Abstract

By reprogramming the tumor microenvironment, renin-angiotensin system inhibitors have the potential to increase effectiveness of immunotherapy.

Funder

National Cancer Institute

Bill and Melinda Gates Foundation

Austrian Science Fund

National Foundation for Cancer Research

Lustgarten Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference197 articles.

1. The renin-angiotensin system and malignancy

2. Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy

3. International union of pharmacology. XXIII. The angiotensin II receptors;de Gasparo M.;Pharmacol. Rev.,2000

4. The renin–angiotensin system and cancer: old dog, new tricks

5. Physiology of Local Renin-Angiotensin Systems

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer;Clinical Genitourinary Cancer;2024-10

2. The role of prehabilitation in HNSCC patients treated with chemoradiotherapy;Supportive Care in Cancer;2024-09-05

3. Activatable Fluorescence and Bio/Chemiluminescence Probes for Aminopeptidases: From Design to Biomedical Applications;Advanced Materials;2024-09-05

4. Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade;Journal for ImmunoTherapy of Cancer;2024-09

5. Regulatory network analysis ofDclk1gene expression reveals a tuft cell-ILC2 axis that inhibits pancreatic tumor progression;2024-08-30